Ilika plc USA Patent grant IP for solid-state batteries

Ilika plc

Ilika plc (LON:IKA), a pioneer in materials innovation and solid-state battery technology, announced today that it has received a granted patent in the USA for its proprietary process for making solid-state batteries which was jointly filed with Toyota Motor Company (‘Toyota’) on 21 July 2011.

This granted patent follows the successful grant of applications from the same patent family in China, Europe and Britain in September 2015, July 2015 and May 2014 respectively. The patent is a member of the patent families that cover the companys proprietary vapour deposition processes used in producing solid-state batteries directly from the basic elements.

This particular joint filing resulted from collaborative work undertaken by IKA and Toyota, which commenced in 2008. This patent family is one of the two earliest filings of a growing portfolio of intellectual property (‘IP’) exemplifying the unique approach to solid-state battery production using evaporation sources. The more recent applications in the portfolio contain both jointly-owned and solely owned IP.

In January 2015, three international patent applications from the portfolio were filed under the Patent Co-operation Treaty based upon earlier British priority applications. These were published in July 2015 and are progressing through the international patent examination process.

The highly scalable stacked cell architecture which the company can produce, enables the simple fabrication of cells over a wide range of sizes. It is initially focusing on micro-batteries designed to power wireless sensors, particularly for industrial and medical applications.

Commenting on this latest development, Graeme Purdy, Ilika Plc CEO, said: “The grant of this patent further demonstrates the strength of the companys growing internationally protected IP portfolio in solid-state batteries. The USA is one of the most globally significant markets for batteries. This patent forms part of the extensive package of know-how and expertise that Ilika intends to license to manufacturing partners.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search